![Christopher J. Barden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Christopher J.
Barden is the founder of DeNovaMed, Inc. and holds the title of Director.
DeNovaMed, Inc. was founded in 2006.
Dr. Barden is the founder of Treventis Corp.
and holds the title of Chief Executive Officer.
Postes actifs de Christopher J. Barden
| Sociétés | Poste | Début |
|---|---|---|
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Directeur Général | - |
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Fondateur | 01/01/2006 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Health Technology |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Health Technology |
